NCT04068610 2026-03-02
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
MedImmune LLC
Phase 1/2 Active not recruiting
MedImmune LLC
NovaOnco Therapeutics Co., Ltd.
Merus B.V.
Eli Lilly and Company
Merck KGaA, Darmstadt, Germany
AstraZeneca
Binex
Poniard Pharmaceuticals